Clinical trial
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic…
NCT00185523 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00185523 |
|---|---|
| Title | Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) |
| Official title | Allogeneic Peripheral Blood Stem Cell Transplantation for Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia in First or Second Remission or Chronic Myelogenous Leukemia in First and Second Chronic Phase or Accelerated Phase |
| Lead sponsor | Stanford University, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Leukemia, Lymphocytic, Acute, Leukemia Acute Promyelocytic Leukemia (APL), Leukemia Acute Lymphoid Leukemia (ALL), Leukemia Chronic Myelogenous Leukemia (CML), Leukemia Acute Myeloid Leukemia (AML), Leukemia Chronic Lymphocytic Leukemia (CLL) |
| Intervention type | Procedure |
| Interventions | Allogeneic hematopoietic cell transplantation |
| Enrollment | 88 |
| Start date | May 1, 2002 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 16, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: